Literature DB >> 18422699

Beta-catenin signalling in mesenchymal islet-derived precursor cells.

L Ikonomou1, E Geras-Raaka, B M Raaka, M C Gershengorn.   

Abstract

OBJECTIVES: Previously, we characterized human islet-derived precursor cells (hIPCs) as mesenchymal stem cells that migrate out from islets in vitro and can differentiate into functional islet-like structures following proliferative expansion. Here, we investigate the role of beta-catenin signalling in derivation and proliferation of hIPCs.
MATERIALS AND METHODS: Localization of beta-catenin was performed using confocal microscopy. Expression levels of beta-catenin target genes were measured by quantitative real-time polymerase chain reaction. Loss-of-function studies were performed using specific short interfering RNAs.
RESULTS: Immunostaining of islet outgrowths revealed translocation of beta-catenin from plasma membranes in intact islets to the nucleus in cells migrating out. There were no nuclear beta-catenin-positive cells in intact islets whereas between 35% and 70% of cells in established hIPC cultures exhibited nuclear beta-catenin. Transcripts for beta-catenin target genes were increased in hIPCs compared to those in islets. Beta-catenin translocated to the cell membrane when hIPCs formed epithelial cell clusters. In proliferating hIPCs, there was a strong correlation between markers of proliferation and nuclear beta-catenin. Treatment of hIPCs with the glycogen synthase kinase-3beta inhibitor (2'Z,3'E)-6-Bromoindirubin-3'-oxime increased intracellular beta-catenin but reduced nuclear beta-catenin, and was associated with reduced cell proliferation. Finally, knockdown of beta-catenin decreased beta-catenin target gene expression and hIPC proliferation.
CONCLUSIONS: These results support a functional role for beta-catenin during proliferation of hIPCs and suggest that activated beta-catenin signalling may also be important during hIPC derivation from islets.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18422699      PMCID: PMC2677447          DOI: 10.1111/j.1365-2184.2008.00527.x

Source DB:  PubMed          Journal:  Cell Prolif        ISSN: 0960-7722            Impact factor:   6.831


  62 in total

Review 1.  How to make pancreatic beta cells--prospects for cell therapy in diabetes.

Authors:  Tomer Nir; Yuval Dor
Journal:  Curr Opin Biotechnol       Date:  2005-10       Impact factor: 9.740

Review 2.  Are better islet cell precursors generated by epithelial-to-mesenchymal transition?

Authors:  Marvin C Gershengorn; Elizabeth Geras-Raaka; Anandwardhan A Hardikar; Bruce M Raaka
Journal:  Cell Cycle       Date:  2005-03-17       Impact factor: 4.534

3.  The Wnt antagonist DICKKOPF-1 gene is a downstream target of beta-catenin/TCF and is downregulated in human colon cancer.

Authors:  José Manuel González-Sancho; Oscar Aguilera; José Miguel García; Natalia Pendás-Franco; Cristina Peña; Santiago Cal; Antonio García de Herreros; Félix Bonilla; Alberto Muñoz
Journal:  Oncogene       Date:  2005-02-03       Impact factor: 9.867

4.  Attenuated Wnt signaling perturbs pancreatic growth but not pancreatic function.

Authors:  Stella Papadopoulou; Helena Edlund
Journal:  Diabetes       Date:  2005-10       Impact factor: 9.461

Review 5.  Molecular requirements for epithelial-mesenchymal transition during tumor progression.

Authors:  Margit A Huber; Norbert Kraut; Hartmut Beug
Journal:  Curr Opin Cell Biol       Date:  2005-10       Impact factor: 8.382

6.  Beta-catenin is essential for pancreatic acinar but not islet development.

Authors:  L Charles Murtaugh; Anica C Law; Yuval Dor; Douglas A Melton
Journal:  Development       Date:  2005-09-28       Impact factor: 6.868

7.  Pancreas-specific deletion of beta-catenin reveals Wnt-dependent and Wnt-independent functions during development.

Authors:  Jessica Dessimoz; Claude Bonnard; Joerg Huelsken; Anne Grapin-Botton
Journal:  Curr Biol       Date:  2005-09-20       Impact factor: 10.834

8.  Epithelial-to-mesenchymal transition generates proliferative human islet precursor cells.

Authors:  Marvin C Gershengorn; Anandwardhan A Hardikar; Chiju Wei; Elizabeth Geras-Raaka; Bernice Marcus-Samuels; Bruce M Raaka
Journal:  Science       Date:  2004-11-25       Impact factor: 47.728

9.  Redifferentiation of insulin-secreting cells after in vitro expansion of adult human pancreatic islet tissue.

Authors:  Andreas Lechner; Anna L Nolan; Robyn A Blacken; Joel F Habener
Journal:  Biochem Biophys Res Commun       Date:  2005-02-11       Impact factor: 3.575

10.  Wnt 3a promotes proliferation and suppresses osteogenic differentiation of adult human mesenchymal stem cells.

Authors:  Genevieve M Boland; Geraldine Perkins; David J Hall; Rocky S Tuan
Journal:  J Cell Biochem       Date:  2004-12-15       Impact factor: 4.429

View more
  4 in total

1.  Ex-vivo Expansion of Adult Human Pancreatic Beta-Cells.

Authors:  Shimon Efrat
Journal:  Rev Diabet Stud       Date:  2008-08-10

2.  Stromal cell-derived factor-1 promotes survival of pancreatic beta cells by the stabilisation of beta-catenin and activation of transcription factor 7-like 2 (TCF7L2).

Authors:  Z Liu; J F Habener
Journal:  Diabetologia       Date:  2009-05-26       Impact factor: 10.122

3.  Human islet-derived precursor cells can cycle between epithelial clusters and mesenchymal phenotypes.

Authors:  Behrous Davani; Sahar Ariely; Laertis Ikonomou; Yoram Oron; Marvin C Gershengorn
Journal:  J Cell Mol Med       Date:  2008-11-03       Impact factor: 5.295

4.  MicroRNA Expression Analysis of In Vitro Dedifferentiated Human Pancreatic Islet Cells Reveals the Activation of the Pluripotency-Related MicroRNA Cluster miR-302s.

Authors:  Guido Sebastiani; Giuseppina Emanuela Grieco; Noemi Brusco; Giuliana Ventriglia; Caterina Formichi; Lorella Marselli; Piero Marchetti; Francesco Dotta
Journal:  Int J Mol Sci       Date:  2018-04-12       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.